Pre-Conference Symposium: SARS-CoV-2

Tuesday, May 18 2021

8:30 am Virtual Coffee & Networking

9:15 am Chair’s Opening Remarks

Synopsis

To read full session information – download the event guide here.

9:30 am Controlled Human Infection Models to Further Validate the Efficacy of COVID-19 Vaccines

Synopsis

To read full session information – download the event guide here.

10:00 am Development of an mRNA-based COVID-19 Vaccine at ‘lightspeed’: From Pre-Clinical Studies to Large-scale Manufacture

Synopsis

To read full session information – download the event guide here.

10:30 am Moderna’s COVID-19 Vaccine: A Summary of Available Clinical Data

Synopsis

To read full session information – download the event guide here.

11:00 am Morning Break & Speed Networking

11:30 am Clinical and Operational Challenges of COVID-19 Vaccine Development and Future Opportunities

Synopsis

To read full session information – download the event guide here.

12:00 pm INO-4800 – A DNA based Vaccine Against COVID-19

Synopsis

To read full session information – download the event guide here.

12:30 pm CVnCov: CureVac’s mRNA-based Vaccine Candidate Against COVID-19

Synopsis

To read full session information – download the event guide here.

1:00 pm Lunch & Virtual Networking Break

2:00 pm Immunogenicity of Chimpanzee Adenovirus Vector Vaccines Expressing SARS-CoV2 Spike and Nucleocapsid

Synopsis

To read full session information – download the event guide here.

2:30 pm Development of AAVCOVID: A Single Dose AAV-based Vaccine for COVID-19

Synopsis

To read full session information – download the event guide here.

3:00 pm A Framework to Analyse the Pandemic Potential of Pathogens: COVID-19 and Future Directions

Synopsis

To read full session information – download the event guide here.

3:30 pm End of SARS-CoV-2 Symposium